APPRAISE 2.0: Live Trial of the APPRAISE Trauma Decision Support System

Sponsor
Andrew Tomas Reisner (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT06121661
Collaborator
(none)
20
1
60

Study Details

Study Description

Brief Summary

This is a pilot evaluation of the APPRAISE trauma decision-support software system ("the

System"). The specific objections are as follows:
  1. Evaluate the robustness of the System (i.e., whether the software performs in real-time in accordance with a priori technical specifications during real-time clinical use);

  2. Evaluate whether the real-time display of the System causes distraction or confusion to clinicians treating the trauma patient such that its risks exceed its benefits;

  3. Collect pilot data to allow for a statistical power analysis to design a future clinical trial evaluating efficacy.

Condition or Disease Intervention/Treatment Phase
  • Device: APPRAISE Trauma Clinical Decision Support System
Phase 1

Study Design

Study Type:
Interventional
Anticipated Enrollment :
20 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Device Feasibility
Official Title:
APPRAISE 2.0: Live Trial of the APPRAISE Trauma Decision Support System
Anticipated Study Start Date :
Dec 15, 2023
Anticipated Primary Completion Date :
Dec 14, 2027
Anticipated Study Completion Date :
Dec 14, 2028

Arms and Interventions

Arm Intervention/Treatment
Experimental: APPRAISE cases

Trauma patients for which APPRAISE system was used

Device: APPRAISE Trauma Clinical Decision Support System
Real-time bedside decision-support system for trauma patient management

Outcome Measures

Primary Outcome Measures

  1. Software session with error messages or critical software errors [From patient arrival in the Emergency Department through enrollment, protocol initiation, and protocol completion (which is typically 30 min after protocol initiation).]

    Each time the software is used ("session"), a log file is generated. We will quantify how many sessions generate error messages or critical software errors.

  2. Clinician surveys that the software negatively affected patient care [From patient arrival in the Emergency Department through enrollment, protocol initiation, and protocol completion (which is typically 30 min after protocol initiation)]

    Each time the software is used, clinicians are surveyed whether the software negatively affected patient care, in their professional judgement

  3. Clinician surveys that the software positively affected patient care [From patient arrival in the Emergency Department through enrollment, protocol initiation, and protocol completion (which is typically 30 min after protocol initiation)]

    Each time the software is used, clinicians are surveyed whether the software negatively affected patient care, in their professional judgement

  4. Clinician surveys that ongoing use of the software poses risks that exceeds benefits [From patient arrival in the Emergency Department through enrollment, protocol initiation, and protocol completion (which is typically 30 min after protocol initiation)]

    Each time the software is used, clinicians are surveyed whether ongoing use of the software poses risks that exceeds benefits

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Adult (≥18 yrs) Emergency Department (ED) patient

  • Triaged to the "Acute" area of the ED. (The "Acute" area is the designated area for ED patients with potential or established critical illness. Triage to Acute is a routine ED operation that is performed based on departmental guidelines and the professional judgement of an experienced triage nurse).

  • Clinical concern for acute injury (based on either an explicitly chief complaint of acute injury, or clinical team with documented concern for acute injury as a relevant part of patient presentation).

Exclusion Criteria:
  • Prisoners

  • Patients known to be pregnant, based on patient report, physical exam, or bedside ultrasound

  • Patients wearing an "EFIC Opt-Out" bracelet

  • Any concern about the suitability of the software system for a specific patient by any clinician involved in the patient's ED care, or by the patient themselves (or by any LAR [lawfully authorized representative] of the patient).

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Andrew Tomas Reisner

Investigators

  • Principal Investigator: Andrew Reisner, MD, Mass. General Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Andrew Tomas Reisner, Principal Investigator; Associate Prof. of Emergency Medicine, Massachusetts General Hospital
ClinicalTrials.gov Identifier:
NCT06121661
Other Study ID Numbers:
  • 2022P001136
First Posted:
Nov 8, 2023
Last Update Posted:
Nov 8, 2023
Last Verified:
Oct 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
Yes
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 8, 2023